Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-08-07
2007-08-07
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007800, C435S007920, C435S235100, C436S086000
Reexamination Certificate
active
10770712
ABSTRACT:
Disclosed herein is a method for following up a prognosis of children with autism before and after treatment with different modalities administered by their clinicians, confirming the involvement of infectious agents, dietary proteins, and toxic chemicals in development of autism. The method utilizes detection of increased amounts of antibodies against an antigen based on infectious agent, toxic chemicals, or dietary proteins. Another method utilizes detection of antibodies to a self-tissue or peptide.
REFERENCES:
New Riverside University Dictionary 1994, p. 445.
A.M. Comi, et al., “Familial Clustering of Autoimmune Disorders and Evaluation of Medical Risk Factors in Autism,”Journal of Child Neurology, vol. 14, #6, Jun. 1999; pp. 388-394.
Stella Chess, et al., “Behavioral Consequences of Congenital Rubella”The Journal of Pediatrics, 1978 vol. 93, #4, pp. 699-703.
M. M. Desmond, et al., “Congenital Rubella Encephalitis,”The Journal of Pediatrics, vol. 71, #3, Sep. 1967, pp. 311-331.
K. Ahlfors, et al., “Congenital Cytomegalovirus Infection and Disease in Sweden and the Relative Importance of Primary and Secondary Maternal Infections,”Scand J. Infect Dis.16: 129-137, 1984.
L. R. Goldman, et al., “Chemicals in the Environment and Developmental Toxicity to Children: A Public Health and Policy Perspective,”Environmental Health Perspectives Supplements, vol. 108, #S3, Jun. 2000, pp. 1-12.
G. J. Myers, et al., “Prenatal Methylmercury Exposure and Children: Neurologic, Developmental, and Behavioral Research,”Environmental Health Perspectives Supplements, vol. 106, #S3, Jun. 1998, pp. 1-13.
P.M. Rodier, et al., “Linking Etiologies in Humans and Animal Models: Studies of Autism,”Reproductive Toxicology., vol. 11, Nos. 2/3, 1997, pp. 417-422.
S.B. Edelson, et al., “Autism: Xenobiotic Influences,”Toxicology and Industrial Health, vol. 14, #6, 1998, pp. 799-811.
Michael B. First, M.D., Editor, “Section 299.00 Autistic Disorder,”Diagnostic and Statistical Manual—Text Revision, American Psychiatric Association, DSM IV-TR™ , 2000.
V. K. Singh, et al., “Circulating Autoantibodies to Neuronal and Glial Filament Proteins in Autism,”Pediatric Neurology, vol. 17, No. 1, 1997, pp. 88-90.
V. K. Singh, et al., “Antibodies to Myelin Basic Protein in Children with Autistic Behavior,”Brain, Behavior, and Immunity7, 97-103 (1993).
A. Vojdani, et al., “Antibodies to Neuron-Specific Antigens in Children with Autism: Possible Cross-Reaction with Encephalitogenic Proteins from Milk,Chlamydia pneumoniaeandStreptococcusGroup A,”Journal of Neuroimmunology, 129 (2002) 168-177.
A. Vojdani, et al., “Infections,Toxic Chemicalsand Dietary Peptides Binding to Lymphocyte Receptors and Tissue Enzymes Are Major Instigators of Autoimmunity in Autism,”International Journal of Immunopathology and Pharmacology, vol. 16, No. 3, 189-199 (2003).
E.L. Cooper, “Neuroimmunology of Autism: A Multifaceted Hypothesis,”International Journal of Immunopathology and Pharmacology, vol. 16, No. 3, 289-292 (2003).
Cheu Jacob
Immunosciences Lab., Inc.
Knobbe Martens Olson and Bear LLP
Le Long V.
LandOfFree
Identification of etiology of autism does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Identification of etiology of autism, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification of etiology of autism will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3898199